Insider Selling: Astera Labs (NASDAQ:ALAB) CEO Sells $18,522,900.00 in Stock

Astera Labs, Inc. (NASDAQ:ALAB) CEO Jitendra Mohan sold 123,750 shares of the firm’s stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $149.68, for a total transaction of $18,522,900.00. Following the completion of the transaction, the chief executive officer directly owned 4,407,982 shares in the company, valued at approximately $659,786,745.76. The trade was a 2.73% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jitendra Mohan also recently made the following trade(s):

• On Wednesday, April 15th, Jitendra Mohan sold 2,967 shares of Astera Labs stock. The shares were sold at an average price of $174.60, for a total transaction of $518,038.20.
• On Tuesday, March 17th, Jitendra Mohan sold 157,500 shares of Astera Labs stock. The shares were sold at an average price of $131.58, for a total transaction of $20,723,850.00.
• On Tuesday, February 17th, Jitendra Mohan sold 94,971 shares of Astera Labs stock. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $170.81 on Friday. Astera Labs, Inc. has a fifty-two week low of $52.56 and a fifty-two week high of $262.90. The stock has a market cap of $29.25 billion, a price-to-earnings ratio of 140.01, a PEG ratio of 3.39 and a beta of 1.78. The firm’s 50-day simple moving average is $129.75 and its 200 day simple moving average is $154.53.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter last year, the firm earned $0.37 EPS. The company’s quarterly revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Institutional Investors Weigh In On Astera Labs

Hedge funds have recently modified their holdings of the stock. Nordea Investment Management AB bought a new stake in shares of Astera Labs in the 4th quarter worth approximately $2,028,000. Geneva Partners LLC purchased a new position in shares of Astera Labs during the 3rd quarter valued at $1,876,000. Numerai GP LLC grew its position in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after purchasing an additional 7,992 shares in the last quarter. Handelsbanken Fonder AB grew its position in shares of Astera Labs by 289.5% during the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after purchasing an additional 93,800 shares in the last quarter. Finally, Corient Private Wealth LLC purchased a new position in shares of Astera Labs during the 2nd quarter valued at $543,000. Institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on ALAB. Royal Bank Of Canada began coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price on the stock. Loop Capital began coverage on shares of Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price on the stock. Barclays set a $165.00 target price on shares of Astera Labs in a research report on Thursday, January 15th. Citigroup began coverage on shares of Astera Labs in a research report on Thursday, April 2nd. They set a “buy” rating and a $200.00 target price on the stock. Finally, Weiss Ratings cut shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Fifteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $199.44.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.